Navigation Links
FDA chief takes decision without two senior officials’ opinion

In a crucial decision taken to delay action on Barr Pharmaceuticals Inc.’s 'morning-after' contraceptive the FDA chief did not take two senior officials opinion.// The FDA is in thick smoke as it has been sued by the non-profit Center for Reproductive Rights saying science was influenced by politics.

Director of the FDA’s Center for Drug Evaluation and Research, Dr. Steven Galson, admitted that he wanted to approve the drug. Still, in Galson’s words, “then Acting FDA Commissioner Lester Crawford told me that he was concerned about where we were heading because he knew that I was heading towards this recommendation, and he told me that he was going to make the decision on what to do with the application.”

A set of pills that can prevent pregnancy if taken within 72 hours of sexual intercourse is what the drug is all about.

The acting chief then, Crawford was confirmed as permanent FDA commissioner in July 2005. Thereafter this delay was announced.

This is the bone of contention and can land him in trouble.
'"/>




Page: 1

Related medicine news :

1. EU medical chief says Europe ready for bird flu
2. Making Budhia run 65 km absolutely cruel,says Infosys chief
3. A&E departments To Be Shut Down warns NHS chief
4. NHS acting chief’s intervie
5. Mittal tightens grip on steel making giant, to be its chief
6. India takes on foot-and-mouth disease by vaccinating animals
7. Roller coaster takes brain for a big ride!!
8. Children! Protecting them from medical mistakes
9. Men who takes risk is unlikely to impress women
10. Research on HIV takes new direction
11. Anorexia nervosa takes its toll on life!!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
(Date:10/12/2017)... ... 2017 , ... On Saturday, October 21, the Health & Wellness Center at ... raise money for the American Heart Association Heart Walk. Teams of up to 10 ... to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology: